- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06276517
Hidden Impairments During Subarachnoid Haemorrhage Recovery, Description and Evolution of a Newly Described Syndrom (HIDDEN)
Study Overview
Status
Conditions
Detailed Description
Every year, subarachnoid hemorrhage affects 9.1 people per 100,000 worldwide, with a peak between the ages of 50 and 60. Its frequency and relatively young age of onset make it a major source of decline in healthy life years.
Progress over the past thirty years has led to a 57% reduction in mortality, but these figures do not always reflect the day-to-day reality of these patients, for whom recovery remains incomplete in almost half of cases. For example, a third of patients have not returned to work at one year, and of those who have, only half have returned to work full-time. In 2020, a Norwegian team showed that, at one year, a third of patients suffer from a "post-HSA syndrome", as yet little described, but which seems very similar to the post-concussion syndrome experienced by patients after head trauma. In their study, only 3% of patients with this syndrome returned to work at one year. A better understanding of the incidence of this syndrome, as well as its evolution and determinants, is therefore essential.
With this in mind, the investigators chose to assess the presence of post-SAH syndrome at 3 months and its repercussions on return to work, using the Rivermead questionnaire.
Secondly, in view of the prevalence of post-traumatic stress syndrome at 3 years (a quarter of patients), the investigators wished to study the factors determining the presence of post-HSA syndrome and an inability to return to work at 3 months, 6 months, 1 year.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Labeyrie Marc-Antoine
- Phone Number: 01 49 95 83 52
- Email: marc-antoine.labeyrie@aphp.fr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
Patient aged 18 to 65
- Patient hospitalized in intensive care unit at Hôpital Lariboisière between September 2022 and September 2023 for subarachnoid hemorrhage due to aneurysmal rupture.
- Patient affiliated to the French social security system
- Patient expressing no objection
Exclusion Criteria:
- Motor deficits persisting 1 month after SAH
- Hospitalization > 1 month
- Patient does not speak French
- Patient with diagnosis of neurodegenerative disease.
- Traumatic meningeal hemorrhage
- Patients on AME
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
patients with subarachnoid hemorrhage
Patients hospitalized in Lariboisière intensive care unit for subarachnoid hemorrhage
|
self-questionnaire with 16 questions, rated from 0 to 4, giving a total of 0 to 52 points.
Other Names:
49-question self-administered questionnaire covering 12 domains (including work/productivity, mood, social roles, family roles, personality, etc.).
Other Names:
multidimensional, generic scale, i.e. one that assesses health status independently of causal pathology, sex, age and treatment
Other Names:
16-question questionnaire with answers rated from 0 to 2 to assess Social reintegration
Other Names:
rapid frontal efficiency battery, 6 tests from 0 to 3 on each side
MoCA is a screening test for neurocognitive impairment.
It comprises 11 categories scored from 0 to 6 for a total of 0 to 30 points.
8 questions rated from 0 to 1 to assess functional outcome
Other Names:
mMRS score from 0 to 4 to assess functional outcome
Other Names:
To assess the prevalence of post-traumatic stress using the PCL-5 self-questionnaire.
PCL-5 is a 20-item self-administered questionnaire.
Other Names:
28-question self-questionnaires to study patients' coping strategies
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluate the presence of post SAH syndrome at 3 months and its impact on return to work using the Rivermead Post-Concussion symptoms questionnaire (RPQ), and its impact on functional outcome.
Time Frame: 3 months
|
The Rivermead questionnaire is a 16-item self-administered questionnaire, rated from 0 to 4, giving a total of 0 to 52 points. This scale was created to assess post-concussion syndrome, which in many ways is similar to what patients experience after a SAH. The higher the score, the greater the difficulties experienced by the patient. A score of 3 or 4 for any of the responses indicates that the patient is incapacitated. |
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
- study the factors determining the presence of a post-HSA syndrome and an inability to return to work at 3 months, 6 months and 1 year
Time Frame: 3 months, 6 months and 1 year,
|
Quality of life assessed using the SS-QoL questionnaire, specific to stroke patients.
Self-questionnaire with 49 questions covering 12 domains (including work/productivity, mood, social roles, family roles, personality).
|
3 months, 6 months and 1 year,
|
To study the prevalence of post-traumatic stress in this population
Time Frame: 3 months, 6 months and 1 year,
|
Assess the prevalence of post-traumatic stress in this population using the PCL-5 self-questionnaire.
PCL-5 is a 20-question self-questionnaire.
|
3 months, 6 months and 1 year,
|
Study patients' coping strategies in relation to functional recovery using the Brief-Cope self-questionnaire
Time Frame: 3 months, 6 months and 1 year,
|
Brief-Cope self-questionnaire (28-question self-questionnaires).
|
3 months, 6 months and 1 year,
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- APHP220918
- 2022-A01739-34 (Other Identifier: IDRCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intracranial Hemorrhages
-
King's College Hospital NHS TrustActive, not recruitingStroke | Intracranial Hemorrhages | Brain AneurysmUnited Kingdom
-
Fondation Ophtalmologique Adolphe de RothschildActive, not recruitingPatients' Follow-up After Subarachnoid Haemorrhage Caused by Ruptured Intracranial Aneurysms (FUSAC)Intracranial AneurysmsFrance
-
NoNO Inc.WithdrawnSubarachnoid Hemorrhage | Ruptured Intracranial AneurysmCanada, United States
-
Walton Centre NHS Foundation TrustUniversity of Liverpool; National Institute for Health Research, United KingdomNot yet recruitingTiming to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage (RESTARTtlCrH)Traumatic Intracranial Haemorrhage
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)CompletedTraumatic Intracranial HaemorrhageCanada
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)UnknownTraumatic Intracranial HaemorrhageCanada
-
Centre hospitalier de l'Université de Montréal...RecruitingIntracranial Hemorrhage Ruptured AneurysmUnited States, Canada, Spain
-
Alexion Pharmaceuticals, Inc.CompletedAcute Intracranial HemorrhageCanada, Denmark, Italy, Netherlands, Spain, United States, Belgium, Switzerland, Germany, Hungary, Russian Federation, Czechia, France, United Kingdom, Israel, Austria, Norway, Latvia, Finland, Poland, Sweden, Portugal, Greece, Lithuania
-
Henry Ford Health SystemUnknownSubarachnoid Hemorrhage | Vasospasm, Intracranial | Cerebral AneurysmUnited States
-
University of California, Los AngelesCompletedSubarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Cerebral Vasospasm | Intracranial AneurysmUnited States
Clinical Trials on questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Minneapolis Veterans Affairs Medical CenterUnited States Department of DefenseCompletedLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury)United States
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Rabin Medical CenterCompleted
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
National Taiwan University HospitalNational Taiwan UniversityUnknownComputerized Physician Order EntryTaiwan